Clinical trial
Personalized Pharmacological Treatment of the Frail Patient: Integrated CARE and Real-Time Monitoring at Home (FRAIL-CARE).
NCT07903584 is registered in ClinicalTrials.gov with Istituti Clinici Scientifici Maugeri SpA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Pharmacological Treatment of the Frail Patient: Integrated CARE and Real-Time Monitoring at Home (FRAIL-CARE).
- Lead sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 24, 2025
- Completion date
- June 30, 2026
- Enrollment
- 40 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
frailty, multimorbidity, polypharmacy (people under treatment with 5 or more drugs)
Arms
As registered; 1 arm.
-
FRAIL-CARE integrated home care
Frail patients older than 65 years with polypharmacy discharged home. For 6 months they use the RiAtlas Healthcare app and Checkme Pro device, are followed remotely by Specialist Operations Centres (weekly calls, alerts, 24/7 urgent support), and have blood levels of prescribed drugs measured at discharge, 3 and 6 months and when clinically needed.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in health-related quality of life (EQ-5D-5L)
Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. The questionnaire evaluates five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.For each dimension, patients select one of five response options, ranging from no problems to extreme problems or inability to perform the activity. Higher levels of reported problems indicate worse health status. The questionnaire also includes a self-rated health scale ranging from 0 (worst imaginable health state) to 100 (best imaginable health state), with higher scores indicating better perceived health. Assessments are performed at enrolment (T0), 3 months (T1), and 6 months (T2)
Lead sponsor's other trials
Istituti Clinici Scientifici Maugeri SpA, most recent start first.
+122 more trials See the organization page
Similar trials
Same condition (Frailty) and phase, most recent start first.
+666 more trials See the condition page